Literature DB >> 11406731

Usefulness of combining necrosis and platelet markers in triaging patients presenting with chest pain to the emergency department.

V L Serebruany1, D J Levine, G V Nair, A F Meister, P A Gurbel.   

Abstract

BACKGROUND: Myocardial injury and platelet activation play important roles in the pathogenesis of unstable coronary syndromes. We sought to determine whether the combined measurement of platelet and necrosis markers would improve risk stratification, and yield higher diagnostic utility in patients presenting to the emergency department with chest pain. METHODS AND
RESULTS: Platelet and soluble P-selectin together with myoglobin, creatine kinase, CK-MB fraction, and troponin I were measured from the autologous samples in 122 consecutive patients. Statistical analysis revealed strong Spearman correlation coefficients (0.141--0.412; p<0.001) between platelet expression of P-selectin and plasma levels of necrosis markers. Platelet P-selectin and necrosis markers were independent predictors (c-index>0.7) for acute myocardial infarction, while plasma P-selectin exhibited random distribution. Elevated soluble P-selectin and myoglobin were the most valuable in identifying patients with congestive heart failure. None of the markers were useful for triaging chest pain patients with unstable angina. Analysis of incremental gains (Chi-squares) reveals that with respect to platelet P-selectin, myoglobin adds 50 % to AMI diagnostic value, and creatine kinase yields an additional 20 % in triaging these patients. The diagnostic value of soluble P-selectin is substantially (72 %) increased by myoglobin measurements, and enhanced even further (44 %) by adding cardiac troponin I for identifying heart failure patients among the chest pain population.
CONCLUSION: Simultaneous determination of platelet and necrosis markers improve the early diagnosis of acute myocardial infarction and congestive heart failure among patients with chest pain presenting into the Emergency Department. Well controlled clinical trials are needed to prove the advantage of combining platelet and necrosis data over presently used techniques in emergency medicine.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11406731     DOI: 10.1023/a:1011280801335

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  32 in total

1.  Risk stratification of emergency department patients with acute coronary syndromes using P-selectin.

Authors:  J E Hollander; M R Muttreja; M R Dalesandro; F S Shofer
Journal:  J Am Coll Cardiol       Date:  1999-07       Impact factor: 24.094

2.  Diagnostic marker cooperative study for the diagnosis of myocardial infarction.

Authors:  J Zimmerman; R Fromm; D Meyer; A Boudreaux; C C Wun; R Smalling; B Davis; G Habib; R Roberts
Journal:  Circulation       Date:  1999-04-06       Impact factor: 29.690

3.  Role of soluble and platelet-bound P-selectin in discriminating cardiac from noncardiac chest pain at presentation in the emergency department.

Authors:  P A Gurbel; D J Kereiakes; M R Dalesandro; R D Bahr; C M O'Connor; V L Serebruany
Journal:  Am Heart J       Date:  2000-02       Impact factor: 4.749

4.  Effects of age and ischemic times on biochemical evidence of myocardial injury after pediatric cardiac operations.

Authors:  D P Taggart; L Hadjinikolas; J Hooper; J Albert; M Kemp; D Hue; M Yacoub; J C Lincoln
Journal:  J Thorac Cardiovasc Surg       Date:  1997-04       Impact factor: 5.209

5.  Levels of expression of P-selectin, E-selectin, and intercellular adhesion molecule-1 in coronary atherectomy specimens from patients with stable and unstable angina pectoris.

Authors:  A N Tenaglia; A J Buda; R G Wilkins; M K Barron; P R Jeffords; K Vo; M O Jordan; B A Kusnick; D J Lefer
Journal:  Am J Cardiol       Date:  1997-03-15       Impact factor: 2.778

Review 6.  The earliest diagnosis of acute myocardial infarction.

Authors:  Y Rozenman; M S Gotsman
Journal:  Annu Rev Med       Date:  1994       Impact factor: 13.739

7.  In vivo platelet activation following myocardial infarction and acute coronary ischaemia.

Authors:  A Hughes; S Daunt; G Vass; J Wickes
Journal:  Thromb Haemost       Date:  1982-10-29       Impact factor: 5.249

8.  Plasma beta-thromboglobulin as a measure of platelet activity. Effect of risk factors and findings in ischemic heart disease and after acute myocardial infarction.

Authors:  C W Pumphrey; J Dawes
Journal:  Am J Cardiol       Date:  1982-12       Impact factor: 2.778

9.  Non-invasive assessment of infarct reperfusion: the predictive power of the time to peak value of myoglobin, CKMB, and CK in serum.

Authors:  H A Katus; K W Diederich; T Scheffold; M Uellner; F Schwarz; W Kübler
Journal:  Eur Heart J       Date:  1988-06       Impact factor: 29.983

10.  Candidates for thrombolysis among emergency room patients with acute chest pain. Potential true- and false-positive rates.

Authors:  T H Lee; M C Weisberg; D A Brand; G W Rouan; L Goldman
Journal:  Ann Intern Med       Date:  1989-06-15       Impact factor: 25.391

View more
  1 in total

Review 1.  Platelet reactivity and the identification of acute coronary syndromes in the emergency department.

Authors:  Chad E Darling; Alan D Michelson; Gregory A Volturo; Karin Przyklenk
Journal:  J Thromb Thrombolysis       Date:  2008-07-04       Impact factor: 2.300

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.